- Published at
- by rttnews.com
mixed
mixed
Adamas Pharma - Starting The Year Off Right?
Shares of Adamas Pharmaceuticals Inc. (ADMS) have recovered 140% from their 52-week low of $1.90 recorded on Mar.18, 2020, and trade around $4.50. Given the strong GOCOVRI sales, improving Namzaric royalties, and the upcoming FDA decision, Adamas is a stock worth following.